The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Research
The volume and pace of cancer research, from preclinical studies to clinical trials and FDA approvals, can make it challenging to stay informed. This section highlights the latest developments and translates complex scientific concepts into clear, accessible insights for both healthcare professionals and the broader public.
GI Oncologist Discusses the Challenge of Translating CHALLENGE Trial Results into Patient Care
By The Cancer News Team
GI oncologist Dr. Ronan Hsieh discusses the CHALLENGE trial, exploring how exercise improves colon cancer survival and the barriers to implementing structured exercise programs in clinical practice.
GI Oncologist Discusses the Challenge of Translating CHALLENGE Trial Results into Patient Care
By The Cancer News Team
GI oncologist Dr. Ronan Hsieh discusses the CHALLENGE trial, exploring how exercise improves colon cancer survival and the barriers to implementing structured exercise programs in clinical practice.
GI Oncologist Discusses the Challenge of Translating CHALLENGE Trial Results into Patient Care
By The Cancer News Team
GI oncologist Dr. Ronan Hsieh discusses the CHALLENGE trial, exploring how exercise improves colon cancer survival and the barriers to implementing structured exercise programs in clinical practice.
What Cancer Doctors Are Saying About Ivermectin and Cancer Treatment
By The Cancer News Team
Oncologists explain why ivermectin is not a proven cancer treatment, summarizing current evidence, ongoing trials in TNBC, and how clinicians address patient misinformation.
What Cancer Doctors Are Saying About Ivermectin and Cancer Treatment
By The Cancer News Team
Oncologists explain why ivermectin is not a proven cancer treatment, summarizing current evidence, ongoing trials in TNBC, and how clinicians address patient misinformation.
What Cancer Doctors Are Saying About Ivermectin and Cancer Treatment
By The Cancer News Team
Oncologists explain why ivermectin is not a proven cancer treatment, summarizing current evidence, ongoing trials in TNBC, and how clinicians address patient misinformation.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body
By The Cancer News Team
Researchers have developed a new method for generating CAR T cells inside the body using targeted lipid nanoparticles, potentially eliminating barriers that contribute to cancer health disparities.
Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body
By The Cancer News Team
Researchers have developed a new method for generating CAR T cells inside the body using targeted lipid nanoparticles, potentially eliminating barriers that contribute to cancer health disparities.
Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body
By The Cancer News Team
Researchers have developed a new method for generating CAR T cells inside the body using targeted lipid nanoparticles, potentially eliminating barriers that contribute to cancer health disparities.
Can Exercise Save Lives After Colon Cancer? New Study Suggests It Might
By The Cancer News Team
A landmark phase 3 trial shows structured exercise after chemotherapy significantly improves survival and reduces recurrence in colon cancer patients.
Can Exercise Save Lives After Colon Cancer? New Study Suggests It Might
By The Cancer News Team
A landmark phase 3 trial shows structured exercise after chemotherapy significantly improves survival and reduces recurrence in colon cancer patients.
Can Exercise Save Lives After Colon Cancer? New Study Suggests It Might
By The Cancer News Team
A landmark phase 3 trial shows structured exercise after chemotherapy significantly improves survival and reduces recurrence in colon cancer patients.
Centering Cancer Patients’ Voices in Global Health Advocacy
By Sujata Ojha, MD
Centering patient voices in global oncology, Dr. Sujata Ojha explores how equitable cancer care depends on grassroots advocacy and inclusive health systems.
Centering Cancer Patients’ Voices in Global Health Advocacy
By Sujata Ojha, MD
Centering patient voices in global oncology, Dr. Sujata Ojha explores how equitable cancer care depends on grassroots advocacy and inclusive health systems.
Centering Cancer Patients’ Voices in Global Health Advocacy
By Sujata Ojha, MD
Centering patient voices in global oncology, Dr. Sujata Ojha explores how equitable cancer care depends on grassroots advocacy and inclusive health systems.
National Cancer Survivors Day 2025: Stories, Support, and What Comes Next
By The Cancer News Team
Celebrating resilience, this article explores the stories, support systems, and survivorship challenges faced by millions on National Cancer Survivors Day 2025.
National Cancer Survivors Day 2025: Stories, Support, and What Comes Next
By The Cancer News Team
Celebrating resilience, this article explores the stories, support systems, and survivorship challenges faced by millions on National Cancer Survivors Day 2025.
National Cancer Survivors Day 2025: Stories, Support, and What Comes Next
By The Cancer News Team
Celebrating resilience, this article explores the stories, support systems, and survivorship challenges faced by millions on National Cancer Survivors Day 2025.
President Joe Biden’s Prostate Cancer Diagnosis: Can It Be Cured?
By Dr. Jordan Ciuro
Dr. Jordan Ciuro explores President Biden’s prostate cancer diagnosis, the evolving role of screening, and the latest immunotherapy options in prostate cancer care.
President Joe Biden’s Prostate Cancer Diagnosis: Can It Be Cured?
By Dr. Jordan Ciuro
Dr. Jordan Ciuro explores President Biden’s prostate cancer diagnosis, the evolving role of screening, and the latest immunotherapy options in prostate cancer care.
President Joe Biden’s Prostate Cancer Diagnosis: Can It Be Cured?
By Dr. Jordan Ciuro
Dr. Jordan Ciuro explores President Biden’s prostate cancer diagnosis, the evolving role of screening, and the latest immunotherapy options in prostate cancer care.
Binaytara Nepal Healthcare Policy Debate
By The Cancer News Team
This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.
Binaytara Nepal Healthcare Policy Debate
By The Cancer News Team
This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.
Binaytara Nepal Healthcare Policy Debate
By The Cancer News Team
This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.